PRF Technologies PRFX
NASDAQ PRFX
$1.00 0.00 (-0.29%)
At close: Aug 21, 2026 · 4:00 PM EDT

PRF Technologies (PRFX) Cash & Current Investments (2019 - 2025)

PRF Technologies' (PRFX) quarterly Cash & Current Investments came in at $4.1 million in Q4 2025, down 2.82% YoY from $4.3 million in Q4 2024, and up 18.52% on a QoQ basis from $3.5 million in Q2 2025.

PRF Technologies (PRFX) Cash & Current Investments (2019 - 2025) Analysis & Trends

PRF Technologies (PRFX) has 7 years of Cash & Current Investments data on file, last reported at $4.1 million in Q4 2025.

  • Quarterly Cash & Current Investments fell 2.82% year-over-year to $4.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.1 million (down 2.82% YoY) and the FY2025 annual result came in at $4.1 million, down 2.82% from the prior year.
  • Cash & Current Investments grew to $4.1 million in Q4 2025, from $3.5 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $19.4 million in Q1 2021 to a low of $2.8 million in Q2 2024.
  • A 5-year average of $10.3 million and a median of $8.6 million in 2023 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2021 — Cash & Current Investments jumped 3137.09% — and 2023, when it tumbled 55.57%.
  • Tracing PRFX's Cash & Current Investments over 5 years: stood at $16.5 million in 2021, then slumped by 38.44% to $10.2 million in 2022, then fell by 21.17% to $8.0 million in 2023, then slumped by 46.91% to $4.3 million in 2024, then declined by 2.82% to $4.1 million in 2025.
  • The last three Cash & Current Investments figures came in at $4.1 million (Q4 2025), $3.5 million (Q2 2025), and $4.3 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 963.33 Mn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 3.66 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 1.68 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 5.80 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 2.66 Bn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 886.50 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 389.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 530.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 164.00 Mn
10 PRF Technologies 647,973.00 -3.49 Mn - 4.14 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 4.14 Mn
Jun 30, 2025 3.49 Mn
Dec 31, 2024 4.26 Mn
Jun 30, 2024 2.79 Mn
Mar 31, 2024 4.33 Mn
Dec 31, 2023 8.03 Mn
Sep 30, 2023 8.59 Mn
Jun 30, 2023 6.16 Mn
Mar 31, 2023 8.15 Mn
Dec 31, 2022 10.18 Mn
Sep 30, 2022 12.98 Mn
Jun 30, 2022 13.87 Mn
Mar 31, 2022 16.57 Mn
Dec 31, 2021 16.54 Mn
Sep 30, 2021 18.34 Mn
Jun 30, 2021 17.80 Mn
Mar 31, 2021 19.44 Mn
Dec 31, 2020 15.68 Mn
Sep 30, 2020 17.72 Mn
Jun 30, 2020 550,000.00